Iovance Biotherapeutics Inc. sell The Goldman Sachs Group, Inc.
Start price
15.07.25
/
50%
€1.60
Target price
15.07.26
€0.86
Performance (%)
52.73%
Price
04.08.25
€2.44
Summary
This prediction is currently active. The price for Iovance Biotherapeutics Inc. has massively increased, which is bad news for the SELL prediction by The_Goldman_Sachs_Gr. This prediction currently runs until 15.07.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Iovance Biotherapeutics Inc. | -4.197% |
| iShares Core DAX® | -0.695% |
| iShares Nasdaq 100 | -0.520% |
| iShares Nikkei 225® | 0.870% |
| iShares S&P 500 | -0.737% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $1.00 price target on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.71
12.05.25
12.05.25
€7.13
12.05.26
12.05.26
42.75%
04.08.25
04.08.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€2.71
17.04.25
17.04.25
€14.08
17.04.26
17.04.26
-9.85%
04.08.25
04.08.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€3.90
03.03.25
03.03.25
€18.11
03.03.26
03.03.26
-37.37%
04.08.25
04.08.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€14.52
29.02.24
29.02.24
€19.38
28.02.25
28.02.25
-72.27%
01.03.25
01.03.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€11.80
20.02.24
20.02.24
€17.55
20.02.25
20.02.25
-53.22%
21.02.25
21.02.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.05
20.11.23
20.11.23
€10.98
20.11.24
20.11.24
53.15%
21.11.24
21.11.24